395
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Predictors of late virologic failure after initial successful suppression of HIV replication on efavirenz-based antiretroviral therapy

, , , , , , , , , & show all

References

  • Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach. Geneva: World Health Organization; 2013. http://www.who.int/hiv/pub/guidelines/arv2013/en. Accessed March 30, 2016.
  • What’s new in monitoring. Fact sheet: HIV treatment and care. Geneva: World Health Organization; 2015. http://www.who.int/hiv/pub/arv/arv2015-monitoring-factsheet/en/. Accessed March 30, 2016.
  • Panel on antiretroviral guidelines for adults and adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed March 30, 2016.
  • Rutherford GW, Anglemyer A, Easterbrook PJ, et al. Predicting treatment failure in adults and children on antiretroviral therapy. AIDS. 2014;28(Suppl 2):S161–S169.10.1097/QAD.0000000000000236
  • Lynen L, An S, Koole O, et al. An algorithm to optimize viral load testing in HIV-positive patients with suspected first-line antiretroviral therapy failure in Cambodia. J Acquired Immune Defic Syndr. 2009;52(1):40–48.10.1097/QAI.0b013e3181af6705
  • Abouyannis M, Menten J, Kiragga A, et al. Development and validation of systems for rational use of viral load testing in adults receiving first-line ART in sub-Saharan Africa. AIDS. 2011;25(13):1627–1635.10.1097/QAD.0b013e328349a414
  • Evans DH, Fox MP, Maskew M, et al. CD4 criteria improves the sensitivity of a clinical algorithm developed to identify viral failure in HIV-positive patients on antiretroviral therapy. J Int AIDS Soc. 2014;17:19139.
  • van Griensven J, Phan V, Thai S, Koole O, Lynen L. Simplified clinical prediction scores to target viral load testing in adults with suspected first line treatment failure in Phnom Penh, Cambodia. PLoS ONE. 2014;9(2):e87879.10.1371/journal.pone.0087879
  • Campbell TB, Smeaton LM, Kumarasamy N, et al. Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: A randomized clinical trial in diverse multinational settings. PLoS Med. 2012;9(8):e1001290.10.1371/journal.pmed.1001290
  • Safren SA, Biello KB, Smeaton L, et al. Psychosocial predictors of non-adherence and treatment failure in a large scale multi-national trial of antiretroviral therapy for HIV: Data from the ACTG A5175/PEARLS Trial. PLoS ONE. 2014;9(8):e104178.10.1371/journal.pone.0104178
  • Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments. AIDS Care. 2000;12(3):255–266.10.1080/09540120050042891
  • Division of AIDS table for grading the severity of adult and pediatric adverse events: December, 2004. Bethesda, MD: NIH/NIAID/DAIDS; 2004. http://www.hptn.org/web%20documents/HPTN046/SSP/Appendices/AppendixE-ToxicityTables_DAIDS_AE_GradingTable_FinalDec2004.pdf. Accessed November 20, 2015.
  • Fox MP, Cutsem G, Giddy J, et al. Rates and predictors of failure of first-line antiretroviral therapy and switch to second-line ART in South Africa. J Acquired Immune Defic Syndr. 2012;60:428–437.10.1097/QAI.0b013e3182557785
  • Barth RE, Aitken SC, Tempelman H, et al. Accumulation of drug resistance and loss of treatment options precede commonly used criteria for treatment failure in HIV-1 subtype-C-infected patients. Antiviral Ther. 2012;17:377–386.
  • Cozzi-Lepri A, Paredes R, Philips AN, et al. The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI. HIV Med. 2012;13:62–72.
  • Working group on modelling of antiretroviral therapy monitoring strategies in sub-Saharan Africa. Sustainable HIV treatment in Africa through viral-load-informed differentiated care. Nature. 2015;528:S68–S76.
  • Ford N, Darder M, Spelman T, Maclean E, Mills E, Boulle A. Early adherence to antiretroviral medication as a predictor of long-term HIV virological suppression: Five-year follow up of an observational cohort. PLoS ONE. 2010;5(5):e10460.10.1371/journal.pone.0010460
  • Palombi L, Marazzi MC, Guidotti G, et al. Incidence and predictors of death, retention, and switch to second‐line regimens in antiretroviral‐treated patients in sub‐Saharan African sites with comprehensive monitoring availability. Clin Infect Dis. 2009;48(1):115–122.10.1086/596722
  • Safren SA, Otto MW, Worth J. Life-steps: Applying cognitive behavioral therapy to HIV medication adherence. Cognitive Behav Pract. 1999;6:332–341.10.1016/S1077-7229(99)80052-2
  • Safren SA, Otto MW, Worth J, et al. Two strategies to increase adherence to HIV antiretroviral medication: Life-steps and medication monitoring. Behav Res Ther. 2001;39(10):1151–1162.10.1016/S0005-7967(00)00091-7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.